103 related articles for article (PubMed ID: 2212539)
21. Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agents.
Shungu DL; Nalin DR; Gilman RH; Gadebusch HH; Cerami AT; Gill C; Weissberger B
Antimicrob Agents Chemother; 1987 Jun; 31(6):949-50. PubMed ID: 3619429
[TBL] [Abstract][Full Text] [Related]
22. Antibacterial activity of teprenone, a non water-soluble antiulcer agent, against Helicobacter pylori.
Ishii E
Zentralbl Bakteriol; 1993 Sep; 280(1-2):239-43. PubMed ID: 8280947
[TBL] [Abstract][Full Text] [Related]
23. Lipolytic activity of Campylobacter pylori: effect of sofalcone.
Slomiany BL; Nishikawa H; Piotrowski J; Okazaki K; Slomiany A
Digestion; 1989; 43(1-2):33-40. PubMed ID: 2806755
[TBL] [Abstract][Full Text] [Related]
24. [Resistance to antibiotics used in Helicobacter pylori infection in children].
Maciorkowska E; Kaczmarski M; Kowalczuk J; Kondej-Muszyńska K; Roszko I; Cieśla J; Zielińska A; Musaibili S
Pol Merkur Lekarski; 2004 Jun; 16(96):543-6. PubMed ID: 15510893
[TBL] [Abstract][Full Text] [Related]
25. [Differences in susceptibility of Helicobacter pylori to macrolide and other antibiotics in tests using blood agar and albumin agar].
Ishii E; Kishi T
Kansenshogaku Zasshi; 1993 Feb; 67(2):137-42. PubMed ID: 8468498
[TBL] [Abstract][Full Text] [Related]
26. Interactions of plaunotol with bacterial membranes.
Koga T; Watanabe H; Kawada H; Takahashi K; Utsui Y; Domon H; Ishii C; Narita T; Yasuda H
J Antimicrob Chemother; 1998 Aug; 42(2):133-40. PubMed ID: 9738829
[TBL] [Abstract][Full Text] [Related]
27. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children.
Kalach N; Bergeret M; Benhamou PH; Dupont C; Raymond J
J Clin Microbiol; 2001 Jan; 39(1):394-7. PubMed ID: 11136811
[TBL] [Abstract][Full Text] [Related]
28. [Drug susceptibility of clinically isolated Helicobacter pylori].
Nakae M; Sugahara Y; Sasaki H; Yasui H; Imai C; Hasegawa Y; Osaka K; Shibasaki K
Jpn J Antibiot; 1998 Apr; 51(4):281-5. PubMed ID: 9644601
[TBL] [Abstract][Full Text] [Related]
29. Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin triple-therapy regimen in a region with high rates of metronidazole resistance.
Wong WM; Gu Q; Wang WH; Fung FM; Berg DE; Lai KC; Xia HH; Hu WH; Chan CK; Chan AO; Yuen MF; Hui CK; Lam SK; Wong BC
Clin Infect Dis; 2003 Oct; 37(7):882-9. PubMed ID: 13130398
[TBL] [Abstract][Full Text] [Related]
30. Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania.
Kupcinskas L; Rasmussen L; Jonaitis L; Kiudelis G; Jørgensen M; Urbonaviciene N; Tamosiunas V; Kupcinskas J; Miciuleviciene J; Kadusevicius E; Berg D; Andersen LP
APMIS; 2013 May; 121(5):431-6. PubMed ID: 23078193
[TBL] [Abstract][Full Text] [Related]
31. Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study.
Armstrong JA; Wee SH; Goodwin CS; Wilson DH
J Med Microbiol; 1987 Dec; 24(4):343-50. PubMed ID: 3694664
[TBL] [Abstract][Full Text] [Related]
32. In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori.
García-Rodríguez JA; García Sánchez JE; García García MI; García Sánchez E; Muñoz Bellido JL
Antimicrob Agents Chemother; 1989 Sep; 33(9):1650-1. PubMed ID: 2817868
[TBL] [Abstract][Full Text] [Related]
33. High Helicobacter pylori resistance to metronidazole but zero or low resistance to clarithromycin, levofloxacin, and other antibiotics in Malaysia.
Goh KL; Navaratnam P
Helicobacter; 2011 Jun; 16(3):241-5. PubMed ID: 21585611
[TBL] [Abstract][Full Text] [Related]
34. Bactericidal activity of antimicrobial agents against slowly growing Helicobacter pylori.
Millar MR; Pike J
Antimicrob Agents Chemother; 1992 Jan; 36(1):185-7. PubMed ID: 1590687
[TBL] [Abstract][Full Text] [Related]
35. Bactericidal and morphological effects of NE-2001, a novel synthetic agent directed against Helicobacter pylori.
Dai G; Cheng N; Dong L; Muramatsu M; Xiao S; Wang MW; Zhu DX
Antimicrob Agents Chemother; 2005 Aug; 49(8):3468-73. PubMed ID: 16048962
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole.
Blacky A; Makristathis A; Apfalter P; Willinger B; Rotter ML; Hirschl AM
Eur J Clin Microbiol Infect Dis; 2005 Apr; 24(4):276-9. PubMed ID: 15902535
[TBL] [Abstract][Full Text] [Related]
37. Potent bactericidal constituents from Mallotus philippinensis against clarithromycin and metronidazole resistant strains of Japanese and Pakistani Helicobacter pylori.
Zaidi SF; Yoshida I; Butt F; Yusuf MA; Usmanghani K; Kadowaki M; Sugiyama T
Biol Pharm Bull; 2009 Apr; 32(4):631-6. PubMed ID: 19336896
[TBL] [Abstract][Full Text] [Related]
38. Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro.
Xia HX; Buckley M; Keane CT; O'Morain CA
J Antimicrob Chemother; 1996 Mar; 37(3):473-81. PubMed ID: 9182104
[TBL] [Abstract][Full Text] [Related]
39. Antiulcer drugs and gastric prostaglandin E2: an in vitro study.
Ota S; Takahashi M; Yoshiura K; Hata Y; Kawabe T; Terano A; Omata M
J Clin Gastroenterol; 1993; 17 Suppl 1():S15-21. PubMed ID: 7904284
[TBL] [Abstract][Full Text] [Related]
40. [Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
Díaz-Reganon J; Alarcón T; Domingo D; López-Brea M
Rev Esp Quimioter; 2006 Mar; 19(1):34-8. PubMed ID: 16688289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
